Global Influenza Vaccination Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 94

Report ID: 6965

Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.

The global Influenza Vaccination market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Influenza Vaccination volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza Vaccination market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals, Inc. (U.S.)
Novartis AG (Europe)
DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
GlaxoSmithKline plc. (Europe)
Hualan Biological Engineering Inc (Asia Pacific)
Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
F. Hoffmann-La Roche Ltd (Europe)
Sanofi (Europe)

Segment by Regions
North America
Europe
China
Japan

Segment by Type
by Technology
Egg Based
Cell Culture
Recombinant
by Vaccines
Fluzone
Flumist
Fluvirin
Fluvax

Segment by Application
Hospitals
Research Organizations

Table of Contents

Executive Summary
1 Influenza Vaccination Market Overview
1.1 Product Overview and Scope of Influenza Vaccination
1.2 Influenza Vaccination Segment by Technology
1.2.1 Global Influenza Vaccination Production Growth Rate Comparison by Technology (2014-2025)
1.2.2 Egg Based
1.2.3 Cell Culture
1.2.4 Recombinant
1.3 Influenza Vaccination Segment by Application
1.3.1 Influenza Vaccination Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Research Organizations
1.4 Global Influenza Vaccination Market by Region
1.4.1 Global Influenza Vaccination Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.4.6 Southeast Asia Status and Prospect (2014-2025)
1.4.7 India Status and Prospect (2014-2025)
1.5 Global Influenza Vaccination Market Size
1.5.1 Global Influenza Vaccination Revenue (2014-2025)
1.5.2 Global Influenza Vaccination Production (2014-2025)

2 Global Influenza Vaccination Market Competition by Manufacturers
2.1 Global Influenza Vaccination Production Market Share by Manufacturers (2014-2019)
2.2 Global Influenza Vaccination Revenue Share by Manufacturers (2014-2019)
2.3 Global Influenza Vaccination Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Influenza Vaccination Production Sites, Area Served, Product Types
2.5 Influenza Vaccination Market Competitive Situation and Trends
2.5.1 Influenza Vaccination Market Concentration Rate
2.5.2 Influenza Vaccination Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Influenza Vaccination Production Market Share by Regions
3.1 Global Influenza Vaccination Production Market Share by Regions
3.2 Global Influenza Vaccination Revenue Market Share by Regions (2014-2019)
3.3 Global Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Influenza Vaccination Production
3.4.1 North America Influenza Vaccination Production Growth Rate (2014-2019)
3.4.2 North America Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Influenza Vaccination Production
3.5.1 Europe Influenza Vaccination Production Growth Rate (2014-2019)
3.5.2 Europe Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Influenza Vaccination Production (2014-2019)
3.6.1 China Influenza Vaccination Production Growth Rate (2014-2019)
3.6.2 China Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Influenza Vaccination Production (2014-2019)
3.7.1 Japan Influenza Vaccination Production Growth Rate (2014-2019)
3.7.2 Japan Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Influenza Vaccination Consumption by Regions
4.1 Global Influenza Vaccination Consumption by Regions
4.2 North America Influenza Vaccination Consumption (2014-2019)
4.3 Europe Influenza Vaccination Consumption (2014-2019)
4.4 China Influenza Vaccination Consumption (2014-2019)
4.5 Japan Influenza Vaccination Consumption (2014-2019)

5 Global Influenza Vaccination Production, Revenue, Price Trend by Type
5.1 Global Influenza Vaccination Production Market Share by Type (2014-2019)
5.2 Global Influenza Vaccination Revenue Market Share by Type (2014-2019)
5.3 Global Influenza Vaccination Price by Type (2014-2019)
5.4 Global Influenza Vaccination Production Growth by Type (2014-2019)

6 Global Influenza Vaccination Market Analysis by Applications
6.1 Global Influenza Vaccination Consumption Market Share by Application (2014-2019)
6.2 Global Influenza Vaccination Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Influenza Vaccination Business
7.1 Abbott (U.S.)
7.1.1 Abbott (U.S.) Influenza Vaccination Production Sites and Area Served
7.1.2 Influenza Vaccination Product Introduction, Application and Specification
7.1.3 Abbott (U.S.) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 AstraZeneca (Europe)
7.2.1 AstraZeneca (Europe) Influenza Vaccination Production Sites and Area Served
7.2.2 Influenza Vaccination Product Introduction, Application and Specification
7.2.3 AstraZeneca (Europe) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 BioCryst Pharmaceuticals, Inc. (U.S.)
7.3.1 BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Production Sites and Area Served
7.3.2 Influenza Vaccination Product Introduction, Application and Specification
7.3.3 BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Novartis AG (Europe)
7.4.1 Novartis AG (Europe) Influenza Vaccination Production Sites and Area Served
7.4.2 Influenza Vaccination Product Introduction, Application and Specification
7.4.3 Novartis AG (Europe) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
7.5.1 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Production Sites and Area Served
7.5.2 Influenza Vaccination Product Introduction, Application and Specification
7.5.3 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 GlaxoSmithKline plc. (Europe)
7.6.1 GlaxoSmithKline plc. (Europe) Influenza Vaccination Production Sites and Area Served
7.6.2 Influenza Vaccination Product Introduction, Application and Specification
7.6.3 GlaxoSmithKline plc. (Europe) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Hualan Biological Engineering Inc (Asia Pacific)
7.7.1 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Production Sites and Area Served
7.7.2 Influenza Vaccination Product Introduction, Application and Specification
7.7.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
7.8.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Production Sites and Area Served
7.8.2 Influenza Vaccination Product Introduction, Application and Specification
7.8.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 F. Hoffmann-La Roche Ltd (Europe)
7.9.1 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Production Sites and Area Served
7.9.2 Influenza Vaccination Product Introduction, Application and Specification
7.9.3 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Sanofi (Europe)
7.10.1 Sanofi (Europe) Influenza Vaccination Production Sites and Area Served
7.10.2 Influenza Vaccination Product Introduction, Application and Specification
7.10.3 Sanofi (Europe) Influenza Vaccination Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

8 Influenza Vaccination Manufacturing Cost Analysis
8.1 Influenza Vaccination Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Influenza Vaccination
8.4 Influenza Vaccination Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Influenza Vaccination Distributors List
9.3 Influenza Vaccination Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Influenza Vaccination Market Forecast
11.1 Global Influenza Vaccination Production, Revenue Forecast
11.1.1 Global Influenza Vaccination Production Growth Rate Forecast (2019-2025)
11.1.2 Global Influenza Vaccination Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Influenza Vaccination Price and Trend Forecast (2019-2025)
11.2 Global Influenza Vaccination Production Forecast by Regions (2019-2025)
11.2.1 North America Influenza Vaccination Production, Revenue Forecast (2019-2025)
11.2.2 Europe Influenza Vaccination Production, Revenue Forecast (2019-2025)
11.2.3 China Influenza Vaccination Production, Revenue Forecast (2019-2025)
11.2.4 Japan Influenza Vaccination Production, Revenue Forecast (2019-2025)
11.3 Global Influenza Vaccination Consumption Forecast by Regions (2019-2025)
11.3.1 North America Influenza Vaccination Consumption Forecast (2019-2025)
11.3.2 Europe Influenza Vaccination Consumption Forecast (2019-2025)
11.3.3 China Influenza Vaccination Consumption Forecast (2019-2025)
11.3.4 Japan Influenza Vaccination Consumption Forecast (2019-2025)
11.4 Global Influenza Vaccination Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Influenza Vaccination Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer